Carol Sweeney, PhD


  • English

Academic Information

  • Departments: Internal Medicine - Professor
  • Divisions: Epidemiology

Academic Office Information

  • 801-581-5865
  • Williams Building
    295 Chipeta Way
    Salt Lake City, UT 84108

Academic Bio

Carol Sweeney, PhD, is an associate professor in the Division of Epidemiology, Department of Medicine at the University of Utah School of Medicine, an investigator at Huntsman Cancer Institute (HCI), and a member of the HCI Cancer Control and Population Sciences Program. She conducts research on cancer epidemiology, with specific interests in the role of common genetic variants in cancer susceptibility and survival, and in the epidemiology of cancer survivors. She is co-director of the Research Education, Training, and Career Development core of the Utah Center for Clinical and Translational Sciences.

Sweeney received an MS degree in environmental health followed by a PhD in epidemiology, both from the University of Washington. She completed a postdoctoral research fellowship in the Division of Molecular Epidemiology, National Center for Toxicological Research, U.S. Food and Drug Administration. In 2000, she received an American Association of Cancer Researchers (AACR) Susan G. Komen Foundation Young Investigator Scholar Award. In 2001, she received an AACR Pfizer Scholar in Cancer Research Award.

Education History

Type School Degree
Postdoctoral Fellowship National Center for Toxicological Research
Molecular Epidemiology
Postdoctoral Fellow
Doctoral Training University of Washington
Graduate Training University of Washington
Environmental Health
Undergraduate Wellesley College
Biological Sciences

Selected Publications

Journal Article

  1. Millar MM, Yoder V, Jozwik D, Espinoza J, Lemons D, Jewell CY, Sweeney C (2021). Improving Central Cancer Registry Surveillance through Interstate Data Exchange of Electronic Pathology Reports. J Registry Manag, 48(2), 59-63.
  2. Bowles TL, Sweeney C, Snyder J, Gygi J, Bott B, Wray D, Yeatman TJ, Sause WT (2021). Impact of rurality on melanoma diagnosis in Utah. Melanoma Manag, 8(2), MMT56.
  3. Gulbahce HE, White S, Herget KA, Stoddard G, Camp NJ, Buys SS, Sweeney C (2020). 21-gene recurrence score testing utilization among older women from different races: A population-based study. J Geriatr Oncol, 12(2), 206-211.
  4. Yuan Y, Van Dyke AL, Petkov VI, Hussey S, Moravec R, Altekruse SF, Sandoval M, Cress RD, Mueller LM, Mogi A, Hernandez BY, Selk FR, Lynch CF, Tucker TC, Lynch MA, Lefante C, Wu XC, Sweeney C, Doherty JA, Penberthy LS (2020). Pathology Laboratory Policies and Procedures for Releasing Diagnostic Tissue for Cancer Research. Arch Pathol Lab Med, 145(2), 222-226.
  5. Cho ME, Sweeney C, Fino N, Greene T, Ramkumar N, Huang Y, Ricardo AC, Shafi T, Deo R, Anderson A, Mills KT, Cheung AK, CRIC Study Investigators (2021). Longitudinal Changes in Prorenin and Renin in the Chronic Renal Insufficiency Cohort. Am J Nephrol, 52(2), 141-151.
  6. Gallicchio L, Elena JW, Fagan S, Carter M, Hamilton AS, Hastert TA, Hunter LL, Li J, Lynch CF, Milam J, Millar MM, Modjeski D, Paddock LE, Reed AR, Moses LB, Stroup AM, Sweeney C, Trapido EJ, West MM, Wu XC, Helzlsouer KJ (2020). Utilizing SEER Cancer Registries for Population-Based Cancer Survivor Epidemiologic Studies: A Feasibility Study. Cancer Epidemiol Biomarkers Prev, 29(9), 1699-1709.
  7. Hanson HA, Leiser CL, Madsen MJ, Gardner J, Knight S, Cessna M, Sweeney C, Doherty JA, Smith KR, Bernard PS, Camp NJ (2020). Family Study Designs Informed by Tumor Heterogeneity and Multi-Cancer Pleiotropies: The Power of the Utah Population Database. Cancer Epidemiol Biomarkers Prev, 29(4), 807-815.
  8. Millar MM, Elena JW, Gallicchio L, Edwards SL, Carter ME, Herget KA, Sweeney C (2019). The feasibility of web surveys for obtaining patient-reported outcomes from cancer survivors: a randomized experiment comparing survey modes and brochure enclosures. BMC Med Res Methodol, 19(1), 208.
  9. Greenberg S, Buys SS, Edwards SL, Espinel W, Fraser A, Gammon A, Hafen B, Herget KA, Kohlmann W, Roundy C, Sweeney C (2019). Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing. Cancer Med, 8(15), 6789-6798.
  10. Hashibe M, Ou JY, Herget K, Bolton D, McPherson J, Hawley C, Garvin J, Doherty JA, Sweeney C (2019). Feasibility of Capturing Cancer Treatment Data in the Utah All-Payer Claims Database. JCO Clin Cancer Inform, 3, 1-10.
  11. AAlAbdulsalam AK, Garvin JH, Redd A, Carter ME, Sweeny C, Meystre SM (2018). Automated Extraction and Classification of Cancer Stage Mentions fromUnstructured Text Fields in a Central Cancer Registry. AMIA Jt Summits Transl Sci Proc, 2017, 16-25.
  12. Sweeney C, Baumgartner KB, Byers T, Giuliano AR, Herrick JS, Murtaugh MA, Slattery ML (2007). Reproductive history in relation to breast cancer risk among Hispanic and non-Hispanic white women. Cancer Causes Control, 19(4), 391-401.


  1. Grossman D, Sweeney C, Doherty JA (2021). The Rapid Rise in Cutaneous Melanoma Diagnoses. [Letter to the editor]. N Engl J Med, 384(14), e54.